Cargando…
The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras(G12D); Pdx1-Cre (KC) mice
The stromal reaction in pancreatic cancer creates a physical barrier that blocks therapeutic intervention and creates an immunosuppressive tumor microenvironment. The Rho/myocardin-related transcription factor (MRTF) pathway is implicated in the hyper-activation of fibroblasts in fibrotic diseases a...
Autores principales: | Leal, Ana S., Misek, Sean A., Lisabeth, Erika M., Neubig, Richard R., Liby, Karen T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506531/ https://www.ncbi.nlm.nih.gov/pubmed/31068602 http://dx.doi.org/10.1038/s41598-019-43430-0 |
Ejemplares similares
-
Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation
por: Foda, Bardees M., et al.
Publicado: (2023) -
Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
por: Misek, SA, et al.
Publicado: (2019) -
Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐Kras(G12D)) mice
por: Yu, Wei, et al.
Publicado: (2021) -
Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered Kras(G12D);Pdx1-Cre mouse (KC) model
por: Rachagani, Satyanarayana, et al.
Publicado: (2015) -
RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling
por: Hayashi, Ken’ichiro, et al.
Publicado: (2014)